View Post

Vaccine Candidate Receives Funding to Combat ‘Super Gonorrhea’

In COVID-19, Latest News by Precision Vaccinations

Massachusetts-based CARB-X announced today it awarded up to $2 million to the Jenner Institute, part of the University of Oxford, UK, to develop a novel vaccine to prevent gonorrhea.
The Jenner Institue‘s gonorrhea vaccine, dmGC_0817560 NOMV, consists of blebs, or fluid-filled blisters, from the outer surface of gonococcus, called Native Outer Membrane Vesicles (NOMV).